IANNOTTI, FABIO ARTURO
 Distribuzione geografica
Continente #
AS - Asia 1.628
NA - Nord America 876
EU - Europa 439
SA - Sud America 282
AF - Africa 33
OC - Oceania 3
AN - Antartide 1
Totale 3.262
Nazione #
US - Stati Uniti d'America 832
SG - Singapore 655
CN - Cina 421
BR - Brasile 220
HK - Hong Kong 176
IT - Italia 169
VN - Vietnam 115
FR - Francia 85
KR - Corea 82
NL - Olanda 55
BD - Bangladesh 52
FI - Finlandia 38
AR - Argentina 32
IN - India 32
JP - Giappone 32
DE - Germania 22
GB - Regno Unito 20
CA - Canada 17
IL - Israele 12
MX - Messico 12
PK - Pakistan 11
ZA - Sudafrica 11
ES - Italia 10
MA - Marocco 7
UA - Ucraina 7
VE - Venezuela 7
ID - Indonesia 6
IQ - Iraq 6
PY - Paraguay 6
SA - Arabia Saudita 6
EC - Ecuador 5
BY - Bielorussia 4
KE - Kenya 4
PL - Polonia 4
RU - Federazione Russa 4
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
IE - Irlanda 3
NI - Nicaragua 3
PE - Perù 3
SE - Svezia 3
TN - Tunisia 3
TR - Turchia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
UZ - Uzbekistan 3
CR - Costa Rica 2
GA - Gabon 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
AL - Albania 1
AQ - Antartide 1
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 3.262
Città #
Singapore 365
Hefei 181
Hong Kong 172
San Jose 156
Santa Clara 142
Beijing 98
Ashburn 89
Seoul 79
Lauterbourg 69
Naples 51
Ho Chi Minh City 42
Los Angeles 39
Dallas 35
Hanoi 34
Council Bluffs 21
New York 20
Helsinki 19
São Paulo 19
Tokyo 19
Buffalo 14
Lappeenranta 14
Rio de Janeiro 14
Shenzhen 11
Minamishinagawa 10
Rome 10
Afragola 8
Casandrino 8
Frankfurt am Main 8
Orem 8
Bengaluru 7
Buenos Aires 7
Da Nang 7
Houston 7
Milan 7
Phoenix 7
Brooklyn 6
Guangzhou 6
Johannesburg 6
London 6
Munich 6
Poplar 6
Amsterdam 5
Brasília 5
Campinas 5
Chennai 5
Mexico City 5
Montreal 5
San Francisco 5
Asunción 4
Falkenstein 4
Florence 4
Haiphong 4
Lahore 4
Marseille 4
Miami 4
Nairobi 4
Nanjing 4
New Orleans 4
Newark 4
Turku 4
Antwerp 3
Belo Horizonte 3
Biên Hòa 3
Boardman 3
Campo Grande 3
Caxias do Sul 3
Dhaka 3
Dublin 3
Goiânia 3
Itajubá 3
Macaé 3
Mumbai 3
Porto Alegre 3
Providence 3
Québec 3
Rabat 3
Salvador 3
Stockholm 3
São Bernardo do Campo 3
São Gonçalo 3
Tashkent 3
Toronto 3
Venice 3
Viamão 3
Warsaw 3
Algiers 2
Alliance 2
Atlanta 2
Auckland 2
Austin 2
Avellaneda 2
Baghdad 2
Baku 2
Barra Bonita 2
Basra 2
Berazategui 2
Bologna 2
Boston 2
Brookfield 2
Bắc Ninh 2
Totale 2.021
Nome #
2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors 123
First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury 98
Orexin-A and endocannabinoids are involved in obesity-associated alteration of hippocampal neurogenesis, plasticity, and episodic memory in mice 90
N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 85
The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity 81
Editorial: "Small molecules targeting transmembrane receptors and ion channels in drug discovery" 80
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity 74
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. 73
N-palmitoyl-d-glucosamine, a natural monosaccharide-based glycolipid, inhibits tlr4 and prevents lps-induced inflammation and neuropathic pain in mice 71
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus. 69
Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis 69
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI 68
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy 66
The (Poly)pharmacology of cannabidiol in neurological and neuropsychiatric disorders: Molecular mechanisms and targets 64
In silico identification and experimental validation of (-)-muqubilin A, a marine norterpene peroxide, as PPARalpha/gamma-RXRalpha agonist and RARalpha positive allosteric modulator 62
The gut microbiome, endocannabinoids and metabolic disorders. 61
TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling 59
Identification and characterization of cannabidiol as an ox1r antagonist by computational and in vitro functional validation 59
Alternanza Scuola Lavoro Liceo Scientifico Galilei-Mondragone (Ce), AS 2017/18 58
Identification of Cannabidiolic and Cannabigerolic Acids as MTDL AChE, BuChE, and BACE‐1 Inhibitors Against Alzheimer's Disease by In Silico, In Vitro, and In Vivo Studies 58
Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin 57
NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 55
Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy 52
Beneficial effects of akkermansia muciniphila are not associated with major changes in the circulating endocannabinoidome but linked to higher mono-palmitoyl-glycerol levels as new pparα agonists 52
Protective Effects of N-Oleoylglycine in a Mouse Model of Mild Traumatic Brain Injury 51
Neuroendocrine Transdifferentiation in Human Prostate Cancer Cells: An Integrated Approach 49
Alternanza Scuola Lavoro Liceo Scientifico Colombo-Marigliano (Na), AS 2017/18 49
Cannabinoids, Endocannabinoids, and Synthetic Cannabimimetic Molecules in Neuromuscular Disorders 48
Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARgamma Agonist via a Combined Computational and Functional Study 47
Activation of cannabinoid type 1 receptor (CB1) modulates oligodendroglial process branching complexity in rat hippocampal cultures stimulated by olfactory ensheathing glia-conditioned medium 46
Maternal omega-3 intake differentially affects the endocannabinoid system in the progeny`s neocortex and hippocampus: Impact on synaptic markers 46
PPARα/γ-Targeting Amorfrutin Phytocannabinoids from Aerial Parts of Glycyrrhiza foetida 46
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 45
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia 45
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 45
Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome 44
Assessment of the effects of dietary vitamin d levels on olanzapine-induced metabolic side effects: Focus on the endocannabinoidome-gut microbiome axis 42
Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice 42
Activation of Kv7 Potassium Channels Inhibits Intracellular Ca2+ Increases Triggered By TRPV1-Mediated Pain-Inducing Stimuli in F11 Immortalized Sensory Neurons 41
The endocannabinoidome in human placenta: Possible contribution to the pathogenesis of preeclampsia 40
The endocannabinoid system and ppars: Focus on their signalling crosstalk, action and transcriptional regulation 39
Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets 39
Phytocannabinoid treatment in a mouse model of West syndrome with spontaneous seizures 38
Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions 35
Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors 35
Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor 35
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels. 34
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG. 33
Peripubertal cannabidiol treatment rescued behavioral and neurochemical abnormalities in MAM model of schizophrenia. 32
Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity 31
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. 31
Early Low-Fat Diet Enriched With Linolenic Acid Reduces Liver Endocannabinoid Tone and Improves Late Glycemic Control After a High-Fat Diet Challenge in Mice 31
Neuroprotective effects of N-oleoylglycine in a mouse model of mild traumatic brain injury 31
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability 30
Study of the expression profile and pharmacological role of CB1 receptor in Duchenne Muscular Dystrophy (DMD) muscles: a new opportunity to reinforce muscle repair and locomotor activity 28
Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation 26
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 25
Identification and characterization of phytocannabinoids as novel dual PPARalpha/gamma agonists by a computational and in vitro experimental approach 25
Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats 24
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in perinatal ?9-tetrahydrocannabinol occurs in schizophrenia: analyses in patients and in animal model of the disease. 24
Pharmacological actions and potential therapeutic use of cannabinoids in Duchenne's muscular dystrophy 23
Nociceptor plasticity: a closer look. 23
The endocannabinoid system controls skeletal muscle cell differentiation via CB1 receptor-dependent hydrolysis of PIP2 and ihibition of Kv7 potassium channels 22
Role of the endocannabinoid system in the control of mouse myometrium contractility during the menstrual cycle 22
Analysis of the "endocannabinoidome" in peripheral tissues of obese Zucker rats 22
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Delta9-tetrahydrocannabinol-exposed rats 22
THE NON-PSYCHOTROPIC PLANT CANNABINOIDS, CANNABIDIOL (CBD) AND CANNABIDIVARIN (CBDV) ACTIVATE AND DESENSITIZE TRPV1 CHANNELS IN VITRO: POTENTIAL FOR THE TREATMENT OF NEURONAL HYPEREXCITABILITY 21
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 21
Experimental ischemia/reperfusion model impairs endocannabinoid signaling and Na+/K+ ATPase expression and activity in kidney proximal tubule cells 21
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system 20
Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood 19
The endocannabinoid system in renal cells: regulation of Na+ transport by CB1 receptors through distinct cell signalling pathways 18
Study of the expression profile and pharmacological role of the CB1 receptor in Duchenne Muscular Dystrophy (DMD) muscles: a new opportunity to reinforce muscle repair and locomotor activity 18
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders 17
Attività laboratoriale "RigenerAzioni per combattere le malattie muscolari degenerative: studio di terapie innovative per ripristinare la rigenerazione tissutale nelle distrofie muscolari" nell'ambito del Progetto "RigenerAzioni: Percorsi di rigenerazione per l'economia circolare, i beni culturali e la salute" - Festival scientifico "Futuro Remoto" XXXII - Città della Scienza, Napoli, 5-8 novembre 2018 15
THE ENDOCANNABINOID SYSTEM CONTROLS SKELETAL MUSCLE CELL DIFFERENTIATION VIA CB1 RECEPTOR-DEPENDENT HYDROLYSIS OF PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE (PIP2) AND INHIBITION OF KV7 POTASSIUM CHANNELS 14
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity 13
Totale 3.367
Categoria #
all - tutte 11.657
article - articoli 10.296
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 122
Totale 22.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024107 0 0 0 0 0 0 0 0 0 5 13 89
2024/20251.138 14 6 98 52 138 25 21 96 67 68 293 260
2025/20262.064 122 232 171 278 364 79 274 77 112 147 118 90
2026/202758 58 0 0 0 0 0 0 0 0 0 0 0
Totale 3.367